# Anlon Healthcare (NSE: AHCL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/AHCL · Pivot · prices to 21 Oct 2026

Anlon Healthcare (NSE: AHCL) closed at ₹25.63 on 21 Oct 2026. With a market capitalisation of ₹1,431 Cr, it ranks 1305th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 44.1× trailing earnings, against a return on equity of 25.5% in FY25. Over the past year the share price has risen 108.5%. Its 52-week range is ₹10.37 (2 Mar 2026) to ₹37.24 (30 Sep 2026); the last close is 31.2% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹88 Cr and net profit ₹8 Cr, on a consolidated basis. Promoters held 52.68% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹25.63 |
| Market cap | ₹1,431 Cr |
| P/E (trailing) | 44.1 |
| ROE | 25.5% (FY25) |
| ROCE | 25.2% (FY25) |
| Debt to equity | 0.73 |
| 52-week high | ₹37.24 (30 Sep 2026) |
| 52-week low | ₹10.37 (2 Mar 2026) |
| 1-year return | +108.5% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹88 Cr | — | ₹8 Cr | — | ₹0.16 |
| Q4 FY26 | ₹51 Cr | +4.0% | ₹11 Cr | −33.5% | ₹2.33 |
| Q3 FY26 | ₹36 Cr | — | ₹5 Cr | — | ₹1.13 |
| Q4 FY25 | ₹49 Cr | — | ₹17 Cr | — | ₹5.15 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹120 Cr | ₹21 Cr |
| FY24 | ₹67 Cr | ₹10 Cr |
| FY23 | ₹113 Cr | ₹6 Cr |
| FY22 | ₹57 Cr | −₹0 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 52.68%
- Foreign institutions: 1.67%
- Domestic institutions: 1.22%
- Non-institutions: 44.43%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Gujarat Kidney And Super Speciality](https://app.pivotnow.in/stock/GKSL) | ₹188.00 | ₹1,482 Cr | 75.5 | — |
| [Amrutanjan Health Care](https://app.pivotnow.in/stock/AMRUTANJAN) | ₹501.00 | ₹1,448 Cr | 25 | — |
| [Jagsonpal Ser](https://app.pivotnow.in/stock/JAGSNPHARM) | ₹217.95 | ₹1,435 Cr | 34.5 | — |
| [TTK Healthcare](https://app.pivotnow.in/stock/TTKHLTCARE) | ₹1,007.60 | ₹1,424 Cr | 21.7 | — |
| [Shalby](https://app.pivotnow.in/stock/SHALBY) | ₹126.00 | ₹1,361 Cr | 38.9 | — |
| [Kopran](https://app.pivotnow.in/stock/KOPRAN) | ₹279.00 | ₹1,347 Cr | 52.3 | — |

## Questions and answers

### What is the share price of Anlon Healthcare today?

Anlon Healthcare (NSE: AHCL) last closed at ₹25.63 on 21 Oct 2026. Its 52-week high is ₹37.24 and its 52-week low is ₹10.37.

### What is the market cap of Anlon Healthcare?

Anlon Healthcare's market capitalisation is ₹1,431 Cr (₹1,431 Cr) at the 19 Oct 2026 close, ranking 1305th among the NSE companies Pivot tracks.

### What is the P/E ratio of Anlon Healthcare?

Anlon Healthcare trades at a trailing P/E of 44.1. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 38.9.

### What is the ROE and ROCE of Anlon Healthcare?

Return on equity was 25.5% in FY25 and return on capital employed was 25.2% in FY25 (standalone figures).

### Is Anlon Healthcare a debt-free company?

No. Anlon Healthcare's debt-to-equity ratio was 0.73 in FY25, with total debt of ₹38 Cr.

### What were Anlon Healthcare's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Anlon Healthcare reported revenue of ₹88 Cr and net profit of ₹8 Cr.

### How has Anlon Healthcare stock performed over the last year?

Anlon Healthcare's share price has risen 108.5% over the past year, +79.4% over three months and +22.4% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of Anlon Healthcare?

As of 30 Jun 2026: promoters 52.68%, foreign institutions 1.67%, domestic institutions 1.22%, non-institutions 44.43%.

### Who are Anlon Healthcare's competitors?

The listed Pharma & Healthcare companies closest to Anlon Healthcare by market cap are Gujarat Kidney And Super Speciality, Amrutanjan Health Care, Jagsonpal Ser, TTK Healthcare, Shalby and Kopran.

### Is Anlon Healthcare a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Anlon Healthcare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on AHCL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.